Reviewed

Acamprosate CA 333MG (Hines VA CMOP) - 36C77025Q0022

Waiver type - Procurement: Nonavailability

Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 11/08/2024

Procurement Summary

This acquisition is for the pharmaceutical Acamprosate CA 333MG EC Tab. The Hines CMOP has critically low stock and requires this pharmaceutical to fulfill veteran prescriptions in support of their medical needs. The drug is used by patients in support of abstinence from alcohol in patients with alcohol dependence.

Waiver Rationale Summary

Although the Buy American Act is applicable to small business set-asides (FAR 25.101(b)), the VA will be exercising an exception to the Buy American Act (FAR 25.103(b) Nonavailability) by utilizing a foreign manufacturer, as no domestic end products were discovered during market research. Government does not expect any offers for domestic; if any domestic offers are received, they will be evaluated IAW FAR 25.106.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Date Submitted

10/29/2024

Procurement Instrument Identifier (PIID)

Solicitation ID

N/A

Procurement Stage

Pre-solicitation

Expected Maximum Duration of the Proposed Waiver

Instant Delivery Only

Waiver Coverage

Individual Waiver

Funding Agency

VETERANS AFFAIRS, DEPARTMENT OF